Enfermedad de Parkinson más allá de lo motor

Lizbeth Vásquez Celaya, Amiel Tamariz Rodríguez, Jaime Rafael Gutiérrez Pérez, Gerardo Marín Márquez, Ma. Rebeca Toledo Cárdenas, Porfirio Carrillo Castilla, Jorge Manzo Denes, Genaro Coria Avila, Luis García Hernández

Resumen


La enfermedad de Parkinson es una patología neurodegenerativa que afecta la motricidad de los pacientes, la cual tiene como alteraciones principales: temblor en estado de reposo, bradicinesia, rigidez y alteración postural. Sin embargo, no son las únicas alteraciones que permiten reconocer la aparición de la enfermedad, pues existe sintomatología no motora que se ha encontrado relacionada con esta patología, como alucinaciones, manías y dolor. El tratamiento antiparkinsoniano, enfocado en mejorar la condición motora del paciente puede dejar estragos no motores que muchas veces son ignorados. Por lo cual en esta revisión hablaremos brevemente de las alteraciones no motoras que se han relacionado con la enfermedad de Parkinson.

 

Abstract

Parkinson's disease is a neurodegenerative pathology affecting the mobility of patients, whose main alterations are: tremor at rest, bradykinesia, rigidity and postural alteration. However, they are not the only alterations that allow recognizing the appearance of the disease, as there are non-motor symptoms that have been found related to this pathology, such as hallucinations, mania and pain. The antiparkinsonian treatment, focused on improving the patient's motor condition can leave non-motor damage that is often ignored. Therefore, in this review we will talk briefly about the non-motor alterations that have been related to Parkinson's disease.

Keywords: Parkinson’s disease; non-motor alterations; alterations associated.


Palabras clave


Enfermedad de Parkinson; alteraciones no motoras; alteraciones asociadas.

Texto completo:

PDF

Referencias


González MR., Morata PJM. & Luque DJD. An essay on the shaking palsy. James Parkinson, 1817. 2013. Vol. 1. 1 – 152.

DeLong, MR. The basal ganglia. Princ. neural Sci. 2000. p. 852 – 862. doi:10.1007/SpringerReference_183113.

Zieher, LM., Brió, MC. & Zorrilla Z.M. Enfermedades degenerativas del sistema nervioso central. Tratado de Psicofarmacología y Neurociencia.. Demencias. 2011. Vol. 4. P. 55 – 99.

Emre, M., Aarsland, D., Brown, R., Burn, D J., Duyckaerts, C., Mizuno, Y., Broe, G A., Cummings, J., Dickson, D W., Gauthier, S., Goldman, J., Goetz, C., Korczyn, A., Lees, A., Levy, R., Litvan, I., McKeith, I., Olanow, W., Poewe, W., Quinn, N., Sampaio, C., Tolosa, E., Dubois, B. Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov. Disord. 2007 22, 1689–1707.

Obeso JA, Olanow CW, Rodriguez-Oroz MC, Krack P, Kumar R, Lang AE. Deep-Brain Stimulation of the Subthalamic Nucleus or the Pars Interna of the Globus Pallidus in Parkinson’s Disease. N. Engl. J. Med. 2001 345, 956–963.

Consejo de Salubridad. Diagnóstico y tratamiento de la enfermedad de Parkinson inicial en el primer nivel de atención. Catálogo Maest. Guías Práctica Clínica 2008 SSA-153-08, 1–6.

Perez-Lloret, S. & Rascol, O. Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease. CNS Drugs 2016 30, 703–717.

Lithgow, B. J. & Shoushtarian, M. Parkinson’s disease: Disturbed vestibular function and levodopa. J. Neurol. Sci. 2015 353, 49–58.

Hunot, S. & Hirsch, E. C. Neuroinflammatory Processes in Parkinson’s Disease. Ann. Neurol. 2003 53, 49–60.

SEDENA & SEMAR. Diagnóstico y tratamiento de la enfermedad de Parkinson inicial en el primer nivel de atención. Cons. Salubr. Gen. 2008 1–6.

Martínez-Jurado, E., Cervantes-Arriaga, A. & Rodriguez-Violante, M. Calidad de vida en pacientes con enfermedad de Parkinson. Rev Mex Neurocienc. 2010 11, 480–6.

Vargas- Barahona, L. M. Enfermedad de Parkinson y la Dopamina. BUN Synapsis 2007 2, 12–16.

Calderón ATJL., Bolaños JR., Carrillo RJD. Rivera SG. Interpretación neuroanatómica de los principales síntomas motores y no-motores de la enfermedad de Parkinson Calderón. Rev. Mex. Neurocienc. 2010 11, 218–225.

Fil, A. Cano-de-la-Cuerda, R., Munoz-Hellin, E., Vela, L., Ramiro-Gonzalez, M., Fernandez-de-las-Penas, C. Pain in Parkinson disease: A review of the literature. Parkinsonism Relat. Disord. 2013 19, 285–294.

Schapira, A. H. V, Chaudhuri, K. R. & Jenner, P. Non-motor features of Parkinson disease. Nat. Publ. Gr. 2017 18, 435–450.

Mondragón RE., Arratíbel EI., Ruiz MJ. Martí MJF. Trastornos del sueño en la enfermedad de Parkinson: insomnio y fragmentación del sueño, hipersomnia diurna, alteraciones del ritmo circadiano y síndrome de apnea del sueño. Rev Neurol 2010 50, 21–26.

Rodríguez VM. Cervantes AA. Detección y manejo de síntomas no motores en la enfermedad de Parkinson: impacto en su prevalencia. Rev Med Chile 2011 139, 1032–1038.

Barone, P. Neurotransmission in Parkinson’s disease: Beyond dopamine. Eur. J. Neurol. 2010 17, 364–376.

Sáez FN., Martí AG. RN., De Fàbregues, O., Álvarez SJ., Casas, M., Hernández VJ. Factores clínicos y psicopatológicos asociados a los trastornos del control de impulsos en la enfermedad de Parkinson. Neurología 2016 31, 231–238.

Ceravolo, R., Rossi, C., Kiferle, L. & Bonuccelli, U. Nonmotor symptoms in Parkinson’s disease: the dark side of the moon. Futur. Neurol. 2010 5, 851–871.

Martinez, MP., Schapira, AHV., Stocchi, F., Sethi, K., Odin, P., MacPhee, G., Brown, R G., Naidu, Y., Clayton, L., Abe, K., Tsuboi, Y., MacMahon, D., Barone, P., Rabey, M., Bonuccelli, U., Forbes, A., Breen, K., Tluk, S., Olanow, CW., Thomas, S., Rye, D., Hand, A., Williams, AJ., Ondo, W., Chaudhuri, K. R. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov. Disord. 2007 22, 1623–1629.

Ondo, WG., Dat VK., Khan, H., Atassi, F., Kwak, C., Jankovic, J. Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology 2001 57, 1392–1396.

Castro GA, Sesar IA, Ares PB. Complicaciones psiquiátricas de la enfermedad de Parkinson: clínica y tratamiento. Rev. Neurol. 2004 39, 646–650.

Ng, A., Chander, RJ., Tan, LCS., Kandiah, N. Influence of depression in mild Parkinson’s disease on longitudinal motor and cognitive function. Park. Relat. Disord. 2015 21, 1056–1060.

Martín LM., Peña, EL. Gutiérrez CJ. R. Fenómenos on-off de conducta en la enfermedad de Parkinson. Psiquiatr. Biológica 2017 24, 36–41.

López-Moríñigo, J. D., Ramos-Ríos, R., Martínez-Formoso, S., Arrojo-Romero, M. & Ecénarro-Tomé, P. Enfermedad de Parkinson y espectro obsesivo-compulsivo. Rev. Neurol. 2009 49, 202–209.

Hou, J.-G. G. & Lai, E. C. Non-motor Symptoms of Parkinson’s Disease. Int. J. Gerontol. 2007 1, 53–64.

Chaudhuri, K. R. & Schapira, A. H. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009 8, 464–474.

Chaudhuri, K. R., Healy, D. G. & Schapira, A. H. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006 5, 235–245.

Fernández, F. M. & González, T. M. Clinical notes Pathological gambling and hypersexuality due to dopaminergic treatment in Parkinson’ s disease. Actas Esp Psiquiatr 2009 37, 118–122.

Chaudhuri, KR., Prieto JC., Naidu, Y., Mitra, T., Frades PB., Tluk, S., Ruessmann, A., Odin, P., Macphee, G., Stocchi, F., Ondo, W., Sethi, K., Schapira, AHV., Castrillo Martinez, JC., Martinez MP. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: An international study using the nonmotor symptoms questionnaire. Mov. Disord. 2010 25, 704–709.

Fitts, W., Weintraub, D., Massimo, L., Chahine, L., Duda, J E., Hurtig, H I., Rick, J. Caregiver report of apathy predicts dementia in Parkinson’s disease. Park. Relat Disord 2016 21, 992–995.

Aarsland, D., Larsen, J P., Lim, N G., Janvin, C., Karlsen, K., Tandberg, E., Cummings, J L. Range of neuropsychiatric disturbances in patients with Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 1999 67, 492–6.

García-Ramos, R., Villanueva, C., del Val, J. & Matías-Guíu, J. Apatía en la enfermedad de Parkinson. Neurología 2010 25, 40–50.

Shiba, M., Bower, JH., Maraganore, DM., McDonnell, SK., Peterson, BJ., Ahlskog, E., Schaid, DJ., Rocca WA. Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control study. Mov Disord 2000 15, 669–677.

Rektorova, I., Aarsland, D., Chaudhuri, K. R. & Strafella, A. P. Nonmotor Symptoms of Parkinson’s Disease. Lancet Neurol 2012 2011, 2–4.

Huber, S. J., Paulson, G. W. & Shuttleworth, E. C. Relationship of motor symptoms, intellectual impairment, and depression in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 1988 51, 855–858.

Oguru, M., Tachibana, H., Toda, K., Okuda, B, Oka, N. Apathy and depression in Parkinson's disease. J. Geriatr. Psychiatry Neurol. 2010 23, 35–41.

Martínez-Ramírez, D., Rodríguez-Violante, M., Cervantes-Arriaga, A. & Morales-Briceño, H. Relación entre el género y los síntomas no motores en pacientes con enfermedad de Parkinson. Arch Neurocien 2013 138, 138–141.

Serrano-Dueñas, M. Dosis bajas de amitriptilina frente a dosis bajas de fluoxetina en el tratamiento de la depresión de enfermos de Parkinson. Rev Neurol 2002 35, 1010–1014.

Walsh, K. & Bennett, G. Parkinson’s disease and anxiety. Postgrad. Med. J. 2001 77, 89–93.

Brown, R. G., Jahanshahi, M., Quinn, N. & Marsden, C. D. Sexual function in patients with Parkinson’s disease and their partners. J. Neurol. Neurosurg. Psychiatry 1990 53, 480–486.

Jankovic, J. Parkinson’s disease: Clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 2008 79, 368–376.

Holroyd, S., Currie, L. & Wooten, G. F. Prospective study of hallucinations and delusions in Parkinson’s disease Prospective study of hallucinations and delusions in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 2001 734–738. doi:10.1136/jnnp.70.6.734

Pappert, E. J., Goetz, C. G., Niederman, F. G., Raman, R. & Leurgans, S. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson’s disease. Mov. Disord. 1999 14, 117–121.

Williams, D. R. & Lees, A. J. Visual hallucinations in the diagnosis of idiopathic Parkinson’s disease: A retrospective autopsy study. Lancet Neurol. 2005 4, 605–610.

Fenelon, G. Hallucinations in Parkinson’s disease: Prevalence, phenomenology and risk factors. Brain 2000 123, 733–745.

Barnes, J., David, A. S. & Lane, G. Visual hallucinations in Parkinson’s disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 2001 70, 727–733.

Giladi, N., Weitzman, N., Schreiber, S., Shabtai, H., Peretz, C. New-Onset Heightened Interest or Drive for Gambling, Eating, Shopping or Sexual Activity in Patients with Parkinson’s disease: The Role of Dopamine Agonist Treatment and Age at Motor Symptoms Onset. J. Psychopharmacol. 2007 21, 501–506.

Pluck, G. C. & Brown, R. G. Apathy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2002 73, 636–642.

Dujardin, K., Sockeel, P., Devos, D., Delliaux, M., Krystkowiak, P., Destée, A., Defebvre, L. Characteristics of apathy in Parkinson’s disease. Mov. Disord. 2007 22, 778–784.

Leentjens, AFG., Dujardin, K., Marsh, L., Martinez M, P., Richard, IH., Starkstein, SE., Weintraub, D., Sampaio, C., Poewe, W., Rascol, O., Stebbins, GT., Goetz, CG. Apathy and anhedonia rating scales in Parkinson’s disease: Critique and recommendations. Mov. Disord. 2008 23, 2004–2014.

Thomas, A., Bonanni, L., Gambi, F., Iorio, A. Di & Onofrj, M. Pathological Gambling in Parkinson's Disease Is Reduced by Amantadine. Ann. Neurol. 2010 68, 401–405.

Voon, V., Sohr, M., Lang, A E.,Potenza, M N.,Siderowf, AD., Whetteckey, J.,Weintraub, D., Wunderlich, GR., Stacy, M. Impulse Control Disorders in Parkinson's Disease: A Multicenter Case – Control Study. Ann Neurol 2011 69, 986–996.

Monreal, J. & Staner, L. Eficacia de risperidona en un caso de manía y enfermedad de Parkinson. Actas Esp Psiquiatr 2014 5, 2–4.

Piallat, B., Polosan, M., Fraix, V., Goetz, L., David, O., Fenoy, A., Torres, N., Quesada, J L., Seigneuret, E., Pollak, P. ,Krack, P., Bougerol, T., Benabid, AL., Chabardès, S. Subthalamic neuronal firing in obsessive-compulsive disorder and Parkinson disease. Ann. Neurol. 2011 69, 793–802.

Alegret, M., Unique, C., Valldoriolf, F., Vendrell, P., Pilleri, M., Rumia, J., Tolosa, E. Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Arch Neurol 2001 58, 1223–7.

Owen, AM., Iddon, JL., Hodges, JR., Summers, BA. Robbins, TW. Spatial and non-spatial working memory at different stages of Parkinson’s disease. Neuropsychologia 1997 35, 519–532.

Lewis, SJG., Slabosz, A., Robbins, T. W., Barker, R. A. & Owen, A. M. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson’s disease. Neuropsychologia 2005 43, 823–832.

Levy, G., Jacobs, Diane M., Tang, MX., Côté, LJ., Louis, E D., Alfaro, B., Mejia, H., Stern, Y., Marder, K. Memory and executive function impairment predict dementia in Parkinson’s disease. Mov. Disord. 2002 17, 1221–1226.

Morris, RG., Downes, JJ., Evenden, J L., Sahakian, B J., Heald, A., Robbins, T W. Planning and spatial working memory in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 1988 51, 757–766.

Katai, S., Maruyama, T., Hashimoto, T. & Ikeda, S. Event based and time based prospective memory in Parkinson’s disease. J Neurol Neurocirugía Psiquiatría. Junio de 2003; 74 (6): 704-9.

Muñiz CJA. Rodríguez FR. Déficit de memoria en pacientes con enfermedad de Parkinson inicial. Mapfre Med. 2007 18, 39–45.

Ostrosky-Solis, F. Características neuropsicológicas de la enfermedad de Parkinson. Rev. Neurol. 2000 30, 788–796.

Higginson, CI., King, D S., Levine, D., Wheelock, V L., Khamphay, NO., Sigvardt, KA. The relationship between executive function and verbal memory in Parkinson´s disease. Brain Cogn. 2003 52, 343–352.

Sage, J. I. Pain in Parkinson’ s Disease. Curr. Treat. Options Neurol. 6, 191–200 (2004).

Hanagasi, H. A., Akat, S., Gurvit, H., Yazici, J. & Emre, M. Pain is common in Parkinson’s disease. Clin. Neurol. Neurosurg. 2011 113, 11–13.

Ha, A. D. & Jankovic, J. Pain in Parkinson’s disease. Mov. Disord. 2012 27, 485–491.

Moreno, C. B., Hernández-Beltrán, N., Munévar, D. & Gutiérrez-Álvarez, A. M. Dolor neuropático central en enfermedad de Parkinson. Neurología 2012 27, 500–503.

Parada BY., Soto LA., Lara FGE., Santos SA., Hernandez RT E., Mesa BY. Síntomas no motores en pacientes con enfermedad de Parkinson. Medisan 2012 21, 1–13.

Qayyum, A., Kabir, A., Jesudasan, M. & Siddiqui, I. Pain in Parkinson’s disease: Analysis and literature review. Clin. Neurol. Neurosurg. 2013 115, 2313–2317.

Poewe, W. Non-motor symptoms in Parkinson’s disease. Eur. J. Neurol. 2008 15, 14–20.

Waseem, S. & Gwinn-hardy, K. Pain in Parkinson'S disease: Common yet seldom recognized symptom is treatable. 2001110-6, 33-46.

Letro, G. H., Quagliato, E. M. A. B. & Viana, M. A. Pain in Parkinson’s disease. Arq Neuropsiquiatr 2009 67, 591–594.

Olanow, C. W., Schapira, A. H. V & Roth, T. Waking up to sleep episodes in Parkinson’s disease. Mov. Disord. 2000 15, 212–215.

Pfeiffer, R. F. Non-motor symptoms in Parkinson’s disease. Park. Relat. Disord. 2016 22, S119–S122.

Whitehead, D. L., Davies, A. D. M., Playfer, J. R. & Turnbull, C. J. Circadian rest-activity rhythm is altered in Parkinson’s disease patients with hallucinations. Mov. Disord. 2008 23, 1137–1145.

Tandberg, E., Larsen, J. P. & Karlsen, K. Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: A community-based study. Mov. Disord. 1999 14, 922–927.

Razmy, A., Lang, A. E. & Shapiro, C. M. Predictors of Impaired Daytime Sleep and Wakefulness in Patients with Parkinson Disease Treated with Older (Ergot) vs Newer (Nonergot) Dopamine Agonists. Arch. Neurol. 2004 61, 97–102.

Postuma, R. B., Lang, A. E., Massicotte-Marquez, J. & Montplaisir, J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006 66, 845–851.

Hobson, D. E., Lang, A E., Martin, W R W., Razmy, A., Rivest, J., Fleming, J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002 287, 455–463.

Marinus, J., Visser, M., Van Hilten, J. J., Lammers, G. J. & Stiggelbout, A. M. Assessment of Sleep and Sleepiness in Parkinson’s disease. Sleep 2003 26, 1049–54.

Sixel-Doring, F., Trautmann, E. & Mollenhauer, B. Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 2011 77, 1048–1054.

Högl, B., Saletu, M., Brandauer, E., Glatzl, S., Frauscher, B., Seppi, K., Ulmer, H., Wenning, G., Poewe, W. Modafinil for the treatment of daytime sleepiness in Parkinson’s Disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 2002 25, 905–909.

Sixel-Doring, F., Trautmann, E. & Mollenhauer, B. Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 2011 77, 1048–1054.

Beyer, P. L., Palarino, M. Y., Michalek, D., Busenbark, K., & Koller, W. C. Weight change and body composition in patients with Parkinson’s disease. J. Am. Diet. Assoc. 199595, 979–983.

Chen, H., Zhang, S. M., Hernán, M. A., Willett, W. C. & Ascherio, A. Weight loss in Parkinson’s disease. Ann. Neurol. 2003 53, 676–679.

Bachmann, C. G. & Trenkwalder, C. Body weight in patients with Parkinson’s disease. Mov. Disord. 2006 21, 1824–1830.

Macia, F., Perlemoine, C., Coman, I., Guehl, D., Burbaud, P., Cuny, E., Gin, H., Rigalleau, V., Tison, F. Parkinson’s disease patients with bilateral subthalamic deep brain stimulation gain weight. Mov. Disord. 2004 19, 206–212.

Sanidad, M. D. E. Guía de Práctica Clínica para el Manejo de Pacientes con Enfermedad de Parkinson. 2014 190.

Sakakibara, R., Kishi, M., Ogawa, E., Tateno, F., Uchiyama, T., Yamamoto, T., Yamanishi, T. Bladder, bowel, and sexual dysfunction in Parkinson’s disease. Parkinsons Dis. 2011: 92460. P. 1 – 21.

Bronner, G. Sexual problems in Parkinson’s disease: The multidimensional nature of the problem and of the intervention. J. Neurol. Sci. 2011 310, 139–143.

Miller, B. L., Cummings, J. L., McIntyre, H., Ebers, G. & Grode, M. Hypersexuality or altered sexual preference following brain injury. J. Neurol. Neurosurg. Psychiatry 1986 49, 867–87.

Custodio, N., Montesinos, R., Lira, D. & Torres, H. Hipersexualidad asociada a pramipexol, en el tratamiento de síntomas parkinsonianos: revisión de la literatura, a propósito de 3 casos. An Fac med. 2010 71, 47–50.

Ueki, A. & Otsuka, M. Life style risks of Parkinson’s disease: Association between decreased water intake and constipation. J. Neurol. 2004 251, 18–23.

Gallagher, D. A., Lees, A. J. & Schrag, A. What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them? Mov. Disord. 2010 25, 2493–2500.

Singaram, C., Gaumnitz, E.A., Torbey, C., Ashraf, W., Quigley, E.M.M., Sengupta, A., Pfeiffer, R. Dopaminergic defect of enteric nervous system in Parkinson’s disease patients with chronic constipation. Lancet 1995 346, 861–864.




DOI: https://doi.org/10.25009/eb.v10i23.2542

Enlaces refback

  • No hay ningún enlace refback.


 

eNeurobiología es una publicación cuatrimestral editada por el Instituto de Investigaciones Cerebrales de la Universidad Veracruzana. Estamos ubicados en Av. Dr. Luis Castelazo Ayala, s/n, colonia Industrial Ánimas, C.P. 91190, Xalapa-Enríquez, Veracruz, México. Teléfono: 8418900 ext. 13062, www.iice.uv.mx; eneurobiologia@uv.mx. Reserva de Derechos al Uso Exclusivo 04-2023-061314100600-102, otorgada por el Instituto Nacional de Derechos de Autor. ISSN: 2007-3054. Esta obra está bajo una Licencia Creative Commons Attribution 4.0 International.